Beacon Pharmaceuticals PLC (DSE: BEACONPHAR)

Beacon Pharmaceuticals Statistics

Total Valuation

Beacon Pharmaceuticals has a market cap or net worth of BDT 30.68 billion. The enterprise value is 37.52 billion.

Market Cap	30.68B
Enterprise Value	37.52B

Important Dates

The last earnings date was Wednesday, November 13, 2024.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	Oct 28, 2024

Share Statistics

Beacon Pharmaceuticals has 231.00 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	231.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	30.01%
Owned by Institutions (%)	0.33%
Float	161.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	4.76
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.44, with a Debt / Equity ratio of 1.58.

Current Ratio	1.44
Quick Ratio	0.68
Debt / Equity	1.58
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	3,872
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -45.80% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-45.80%
50-Day Moving Average	125.16
200-Day Moving Average	172.41
Relative Strength Index (RSI)	56.42
Average Volume (20 Days)	211,598

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	n/a
Pretax Income	n/a
Net Income	n/a
EBITDA	n/a
EBIT	n/a
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has 3.37 billion in cash and 10.21 billion in debt, giving a net cash position of -6.84 billion or -29.60 per share.

Cash & Cash Equivalents	3.37B
Total Debt	10.21B
Net Cash	-6.84B
Net Cash Per Share	-29.60
Equity (Book Value)	6.45B
Book Value Per Share	27.93
Working Capital	4.08B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 1.51%.

Dividend Per Share	2.00
Dividend Yield	1.51%
Dividend Growth (YoY)	25.00%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	1.51%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

The last stock split was on November 27, 2011. It was a forward split with a ratio of 1.05.

Last Split Date	Nov 27, 2011
Split Type	Forward
Split Ratio	1.05

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a